Table 3. Clinical data after 24-h treatment and at 1-month follow-up.

	Levosimendan (n = 30)	Control (n = 29)	p value
Clinical data after 24-h
Urine discharge (ml)	1923 ± 285	1761 ± 256	0.026
Systolic BP (mmHg)	111.47 ± 24.13	118.03 ± 13.63	0.205
Diastolic BP (mmHg)	66.37 ± 14.59	70.83 ± 10.64	0.186
Heart rate (bpm)	69.03 ± 15.82	73.86 ± 10.67	0.176
SCr (μmol/L)	95.26 ± 26.68	103.56 ± 46.25	0.401
BNP (ng/ml)	957.95 (727.74, 1322.84)	1302.16 (1006.99, 1666.35)	0.005
1-month follow-up
Death, n (%)	1 (3.3)	1 (3.4)	0.487
Hospitalization (days)	13.60 ± 3.97	11.52 ± 6.02	0.121
Readmission, n (%)	0 (0)	1 (3.4)	0.492

BNP, B-type natriuretic peptides; BP, blood pressure; SCr, serum creatinine.